KPIs & Operating Metrics(New)
Breakdown Of AssetsCost Of Product SalesDeferred RevenueEmployee StatisticsGross Margin %Gross ProfitOpex As A % Of Total Revenue %OPEX SegregationProperty And EquipmentRevenue By Category Contract Revenue From CollaborationsRevenue By Category Contract Revenue From Collaborations AnnualRevenue By Collaborative Partners AnnualRevenue By Major CustomersRevenue By Major Customers %Revenue By Major Customers AnnualRevenue By Major Customers Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %Total Bottles ShippedTotal Bottles Shipped Annual
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rigel Pharmaceuticals (RIGL) Gross Profit: 2009-2025

Historic Gross Profit for Rigel Pharmaceuticals (RIGL) over the last 12 years, with Sep 2025 value amounting to $64.7 million.

  • Rigel Pharmaceuticals' Gross Profit rose 36.86% to $64.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $262.6 million, marking a year-over-year increase of 86.49%. This contributed to the annual value of $160.6 million for FY2024, which is 46.33% up from last year.
  • Per Rigel Pharmaceuticals' latest filing, its Gross Profit stood at $64.7 million for Q3 2025, which was down 33.41% from $97.2 million recorded in Q2 2025.
  • In the past 5 years, Rigel Pharmaceuticals' Gross Profit registered a high of $97.2 million during Q2 2025, and its lowest value of $16.6 million during Q1 2022.
  • Moreover, its 3-year median value for Gross Profit was $34.0 million (2024), whereas its average is $43.7 million.
  • In the last 5 years, Rigel Pharmaceuticals' Gross Profit tumbled by 79.41% in 2022 and then spiked by 185.54% in 2025.
  • Over the past 5 years, Rigel Pharmaceuticals' Gross Profit (Quarterly) stood at $19.9 million in 2021, then spiked by 155.68% to $50.9 million in 2022, then plummeted by 37.17% to $32.0 million in 2023, then spiked by 61.89% to $51.8 million in 2024, then skyrocketed by 36.86% to $64.7 million in 2025.
  • Its Gross Profit was $64.7 million in Q3 2025, compared to $97.2 million in Q2 2025 and $48.9 million in Q1 2025.